Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2B | Q02880 | 2/20 | 0.38 |
| ▸ | EHMT2 | Q96KQ7 | 5/20 | 0.38 |
| ▸ | TOP2A | P11388 | 1/20 | 0.35 |
| ▸ | KAT2B | Q92831 | 3/20 | 0.35 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.35 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.35 |
| ▸ | EIF2AK2 | P19525 | 1/20 | 0.35 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.35 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 5/20 | 0.33 |
| ▸ | NQO1 | P15559 | 3/20 | 0.33 |
| ▸ | MITF | O75030 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7818744 | 0.96 | TOP2B (0.36) | TOP2BEHMT2TOP2AKAT2BMAPK13 | |
| Maleic Acid SCHEMBL7823996 | 0.93 | ECE1 (0.38) | TOP2BEHMT2TOP2AKAT2BMALT1 | |
| Fumaric Acid SCHEMBL7824000 | 0.93 | ECE1 (0.38) | TOP2BEHMT2TOP2AKAT2BMALT1 | |
| SCHEMBL7808632 | 0.92 | TOP2A (0.41) | TOP2BEHMT2TOP2AMALT1 | |
| SCHEMBL7809534 | 0.89 | TOP2A (0.40) | TOP2BEHMT2TOP2AKAT2BMALT1 | |
| SCHEMBL7809384 | 0.88 | TOP2A (0.41) | TOP2BEHMT2TOP2ANQO2 | |
| SCHEMBL7819388 | 0.85 | TOP2A (0.40) | TOP2BEHMT2TOP2AKAT2BNQO2 | |
| SCHEMBL7817084 | 0.84 | TOP2A (0.41) | TOP2BEHMT2TOP2ANQO2NQO1 | |
| SCHEMBL7816908 | 0.82 | TOP2A (0.38) | TOP2BEHMT2TOP2AMALT1 | |
| SCHEMBL8542449 | 0.82 | TOP2B (0.49) | TOP2BEHMT2TOP2AMALT1NQO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0750619-B1 | HETERO-ANNULATED INDAZOLES | NOVUSPHARMA SPA (IT) | 2001-05-30 | — | — | EP | claimed |
| US-5596097-A | ANTITUMOR AGENTS | THE UNIVERSITY OF VERMONT (US) | 1997-01-21 | — | — | US | claimed |
| EP-0750619-A1 | HETERO-ANNULATED INDAZOLES | BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) | 1997-01-02 | — | — | EP | claimed |
| WO-1995024407-A1 | HETERO-ANNULATED INDAZOLES | BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) | 1995-09-14 | — | — | WO | claimed |
| EP-0750619-B1 | HETERO-ANNULATED INDAZOLES | NOVUSPHARMA SPA (IT) | 2001-05-30 | — | — | EP | disclosed |
| US-5596097-A | ANTITUMOR AGENTS | THE UNIVERSITY OF VERMONT (US) | 1997-01-21 | — | — | US | disclosed |
| EP-0750619-A1 | HETERO-ANNULATED INDAZOLES | BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) | 1997-01-02 | — | — | EP | disclosed |
| WO-1995024407-A1 | HETERO-ANNULATED INDAZOLES | BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) | 1995-09-14 | — | — | WO | disclosed |